| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily C member 5 | 0.606 | 0.654 | 4.2E-03 |
|
disease | 0.040 | None | 0.500 | 4 | 0 | 2011 | 2018 | ||||||||
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2015 | ||||||||
|
ATP binding cassette subfamily D member 2 | 0.711 | 0.500 | 4.7E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
ATP binding cassette subfamily E member 1 | 0.674 | 0.462 | 0.97 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2019 | ||||||||
|
ATP binding cassette subfamily G member 1 | 0.560 | 0.692 | 0.11 |
|
disease | 0.050 | None | 1.000 | 5 | 2 | 2005 | 2019 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
disease | 0.400 | None | 0.960 | 75 | 2 | 2000 | 2019 | ||||||||
|
abhydrolase domain containing 12B | 0.931 | 0.115 | 3.8E-15 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
abhydrolase domain containing 14B | 0.931 | 0.077 | 1.4E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
abhydrolase domain containing 8 | 0.861 | 0.192 | 0.97 |
|
disease | 0.100 | None | 1.000 | 1 | 6 | 2010 | 2010 | ||||||||
|
abl interactor 1 | 0.641 | 0.538 | 0.64 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2011 | ||||||||
|
abl interactor 2 | 0.700 | 0.423 | 0.43 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 13 | 0 | 1999 | 2018 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.100 | None | 1.000 | 11 | 1 | 1984 | 2020 | |||||||||
|
ABR activator of RhoGEF and GTPase | 0.650 | 0.500 | 0.63 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
abraxas 1, BRCA1 A complex subunit | 0.760 | 0.269 | 5.1E-07 |
|
disease | 0.350 | None | 0.714 | 7 | 2 | 2009 | 2019 | ||||||||
|
acetyl-CoA carboxylase alpha | 0.480 | 0.846 | 1.00 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2004 | 2018 | ||||||||
|
acyl-CoA dehydrogenase family member 8 | 0.506 | 0.885 | 5.6E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
acyl-CoA dehydrogenase medium chain | 0.638 | 0.462 | 2.1E-12 |
|
disease | 0.310 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
acyl-CoA dehydrogenase short/branched chain | 0.691 | 0.500 | 2.7E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 | 0.839 | 0.269 | 6.8E-02 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
acetyl-CoA acetyltransferase 2 | 0.686 | 0.462 | 5.5E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
acyl-CoA binding domain containing 3 | 0.805 | 0.385 | 1.1E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
1-aminocyclopropane-1-carboxylate synthase homolog (inactive) | 0.522 | 0.731 | 9.0E-07 |
|
disease | 0.320 | None | 1.000 | 2 | 1 | 2017 | 2018 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.100 | None | 0.808 | 26 | 2 | 2003 | 2019 |